Sylvie Ryckebusch advises biotech, pharmaceutical, and venture capital companies on business development strategy and assists in implementation. Her expertise includes commercial and partnering strategy, financial models (risk adjusted NPV), presentations, deal structuring, negotiation of term sheets and full license agreements. She also assists companies seeking non-dilutive financing from government or philanthropic organizations. Sylvie has 17 years of business development experience, and was formerly Head of Neurology and Autoimmune Disease licensing within Merck Serono International where she concluded a number of licensing transactions. She has also worked for Index Ventures, and was an engagement manager with McKinsey & Company. Sylvie holds degrees in mathematics and physics, a PhD in neurosciences from the California Institute of Technology, and was a postdoctoral fellow at the Harvard Business School.